Home » Topics » BioWorld Science

BioWorld Science
RSS

Heptares Therapeutics discovers muscarinic M1 and/or M4 receptor agonists

Jan. 10, 2020

Drexel University synthesizes new HIV capsid assembly inhibitors

Jan. 10, 2020

Aduro BioTech identifies cGAS inhibitors

Jan. 10, 2020

Dana-Farber Cancer Institute discloses new EGFR inhibitors

Jan. 10, 2020

Novartis patents new compounds for leishmaniasis and trypanosomiasis

Jan. 10, 2020

Locus begins phase Ib trial of CRISPR Cas3-enhanced bacteriophage product LBP-EC01

Jan. 10, 2020

Phase III CONSTANT trial of Sci-B-Vac meets primary and secondary endpoints

Jan. 10, 2020

Regeneron announces phase II data for garetosmab in fibrodysplasia ossificans progressiva

Jan. 10, 2020

Positive 6-month data from ongoing phase I/II study in X-linked retinitis pigmentosa

Jan. 10, 2020

Human CD83 CAR T cells for the prevention of GvHD and treatment of AML

Jan. 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...